The FDA has approved a new combination regimen for certain patients with esophageal cell squamous cell carcinoma.

Late Stage Cancer

June 16, 2025 by Fightec.org

https://www.aacr.org/patients-caregivers/progress-against-cancer/tislelizumab-jsgr-plus-chemotherapy-approved-as-first-line-option-for-esophageal-cancer/